You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Replaces remaining uses of "Enterobacteriaceae" with "Enterobacterales" in system resources.
Adds new drugs for CLSI: Cepirome, Ceftobiprole (30ug), Cefepime/Enmatazobactam and Cefepime/Taniborbactam.
Adds quality control ranges for the new drugs.
Fixes potency notation on SMX, SOX, and SSS breakpoints.
Upgrade the installer package to WiX 5.
Broaden the CLSI B. cepacia comples breakpoints to apply to the "BCX" species group instead of the "species"-level code only.
Adds breakpoints for several drugs which were not defined by CLSI, but were defined by FDA to the CLSI 2024 breakpoint set (does not implement FDA as its own separate guideline type).